| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 15,031 | 12,650 | 18,267 | 13,796 | | Cost of Revenue | 18,835 |
-
|
-
|
-
| | | Gross Profit | (3,804) | 12,650 | 18,267 | 13,796 | | | Operating Expenses | | Research Development | (761) | 761 |
-
|
-
| | Selling General and Administrative | (1,443) | 13,430 | 12,659 | 15,281 | | Non Recurring |
-
|
-
| 4,949 |
-
| | Others | (1,065) | 1,065 | 2,312 | 1,152 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (535) | (2,606) | (1,653) | (2,637) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 47 | 287 | (115) | 255 | | Earnings Before Interest And Taxes | (488) | (2,319) | (1,768) | (2,382) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (488) | (2,319) | (1,768) | (2,382) | | Income Tax Expense | 39 | 38 | 39 | 38 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (527) | (2,357) | (1,807) | (2,420) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (527) | (2,357) | (1,807) | (2,420) | | Preferred Stock And Other Adjustments | (2,121) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,648) | ($2,357) | ($1,807) | ($2,420) |
|
0.17% Nasdaq 
Income Statement
